Weight-loss surgery may reduce pancreatic cancer risk in people with obesity

FHS
October 9, 2024
12:42 pm

Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death rate.

FDA clears digital stethoscope company’s AI algorithm for heart failure

An AI algorithm to detect heart failure, embedded in a digital stethoscope, earned clearance from the Food and Drug Administration on Tuesday. The goal is

April 2, 2024

Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma – Biotech Investments

EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma 04.12.2023 / 10:00 CET/CEST The issuer is

December 5, 2023

A Look at the Multiple Myeloma Data Leading to Blenrep’s Withdrawal

In the DREAMM-3 trial, belantamab mafodotin (belamaf; Blenrep) did not improve progression-free survival (PFS) in patients with relapsed/refractory multiple myeloma when compared with pomalidomide (Pomalyst)

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.